Ivan P. Gergel - Net Worth and Insider Trading
Ivan P. Gergel Net Worth
The estimated net worth of Ivan P. Gergel is at least $54,896 dollars as of 2024-11-13. Ivan P. Gergel is the SVP & Chief Medical Officer of Nektar Therapeutics and owns about 41,575 shares of Nektar Therapeutics (NKTR) stock worth over $54,879. Ivan P. Gergel is also the EVP, R&D and CSO of Endo International PLC and owns about 27,649 shares of Endo International PLC (ENDPQ) stock worth over $17. Details can be seen in Ivan P. Gergel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ivan P. Gergel has not made any transactions after 2017-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ivan P. Gergel
Ivan P. Gergel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ivan P. Gergel owns 4 companies in total, including Neurotrope Inc (NTRP) , Corium International Inc (CORI) , and Nektar Therapeutics (NKTR) among others .
Click here to see the complete history of Ivan P. Gergel’s form 4 insider trades.
Insider Ownership Summary of Ivan P. Gergel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTRP | Neurotrope Inc | 2020-03-20 | director |
| CORI | Corium International Inc | 2018-11-27 | director |
| NKTR | Nektar Therapeutics | 2017-10-02 | SVP Drug Development & CMO |
 | | 2014-03-10 | EVP & R&D and CSO |
Ivan P. Gergel Latest Holdings Summary
Ivan P. Gergel currently owns a total of 2 stocks. Among these stocks, Ivan P. Gergel owns 41,575 shares of Nektar Therapeutics (NKTR) as of October 2, 2017, with a value of $54,879 and a weighting of 99.97%. Ivan P. Gergel also owns 27,649 shares of Endo International PLC (ENDPQ) as of March 10, 2014, with a value of $17 and a weighting of 0.03%.
Latest Holdings of Ivan P. Gergel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2017-10-02 | 41,575 | 1.32 | 54,879 |
| ENDPQ | Endo International PLC | 2014-03-10 | 27,649 | 0.00 | 17 |
Holding Weightings of Ivan P. Gergel
Ivan P. Gergel Form 4 Trading Tracker
According to the SEC Form 4 filings, Ivan P. Gergel has made a total of 0 transactions in Nektar Therapeutics (NKTR) over the past 5 years. The most-recent trade in Nektar Therapeutics is the sale of 100,000 shares on October 2, 2017, which brought Ivan P. Gergel around $2 Million.
According to the SEC Form 4 filings, Ivan P. Gergel has made a total of 0 transactions in Endo International PLC (ENDPQ) over the past 5 years. The most-recent trade in Endo International PLC is the sale of 75,637 shares on March 10, 2014, which brought Ivan P. Gergel around $5 Million.
Insider Trading History of Ivan P. Gergel
- 1
Ivan P. Gergel Trading Performance
Ivan P. Gergel Ownership Network
Ownership Network List of Ivan P. Gergel
Ownership Network Relation of Ivan P. Gergel
Ivan P. Gergel Owned Company Details
What does Neurotrope Inc do?
Who are the key executives at Neurotrope Inc?
Ivan P. Gergel is the director of Neurotrope Inc. Other key executives at Neurotrope Inc include director & Chief Executive Officer Charles S. Ryan , COO and General Counsel Michael Ciraolo , and See Remarks Robert Weinstein .
Neurotrope Inc (NTRP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neurotrope Inc (NTRP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurotrope Inc (NTRP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neurotrope Inc (NTRP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurotrope Inc Insider Transactions
Ivan P. Gergel Mailing Address
Above is the net worth, insider trading, and ownership report for Ivan P. Gergel. You might contact Ivan P. Gergel via mailing address: C/o Nektar Therapeutics, 455 Mission Bay Blvd South, San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
